BioRender 图标

Enterocyte (epithelial���mesenchymal transition, stage 3)

Enterocyte (epithelial–mesenchymal transition, stage 3) - Editable icon of a spindle-shaped mesenchymal cell that is undergoing epithelial-mesenchymal transition, stage 3 of 4

[{"image":"https://icons.cdn.biorender.com/w75xh75/5ca75b9a1177743300099887/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5ca75b9a1177743300099887/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5ca75b9a1177743300099885/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5ca75b9a1177743300099885/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d23f8/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d23f8/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d23f9/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d23f9/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d23fa/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d23fa/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d23fb/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d23fb/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d23fc/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d23fc/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d23fd/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d23fd/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d23fe/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d23fe/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d23ff/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d23ff/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2400/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2400/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2401/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2401/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2402/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2402/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2403/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2403/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2404/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2404/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2405/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2405/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2406/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2406/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2407/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2407/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2408/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2408/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2409/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2409/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d240a/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d240a/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d240b/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d240b/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d240c/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d240c/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d240d/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d240d/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d240e/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d240e/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d240f/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d240f/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2410/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2410/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2411/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2411/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2412/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2412/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2413/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2413/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2414/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2414/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2415/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2415/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2416/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2416/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2417/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2417/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2418/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2418/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2419/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2419/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d241a/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d241a/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d241b/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d241b/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d241c/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d241c/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d241d/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d241d/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d241e/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d241e/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d241f/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d241f/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2420/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2420/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2421/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2421/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2422/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2422/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2423/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2423/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2424/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2424/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2425/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2425/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2426/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2426/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2427/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2427/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2428/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2428/5ca75b70117774330009987e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d74f6cc5a4ff7a190d2429/5ca75b70117774330009987e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d74f6cc5a4ff7a190d2429/5ca75b70117774330009987e.png"}]

使用此图标 – 免费
注册无需信用卡。

此图标可在 BioRender 中完全编辑

  • 添加文本、形状及其他图标
  • 搜索 50,000 多种科学准确的图标
  • 重新着色并重新排列每一个图标、线条和标签
  • 导出或分享以满足任何使用需求
Scientist Avatars

加入 400 多万名科学家 的行列,制作可直接用于发表的图表

从图标到成品图表,只需几分钟

  • 搜索 来自 50,000 多个科学准确、经同行评审的图标
  • 自定义 添加标签、形状和更多图标——一切皆可完全编辑
  • 导出 或与协作者分享您的图表
    ‍

图标不合适?探索更多内容。

搜索涵盖 30 多个生命科学领域的 50,000 多个图标。

search icon
arrow-right

intestine,gi,gastrointestinal,intestinal,enterocyte,columnar cell,ciliated,epithelial cell,mesenchymal cell,stem cell,healing,wound,fibrosis,metastasis,cancer,epithelial,mesenchymal,EMT,transition,epithelial to mesenchymal transition,oncology

查看更多

尝试使用同义词,或注册以在应用中请求图标。

图像类型

Enterocyte (epithelial���mesenchymal transition, stage 3) icon JPEG

Enterocyte (epithelial���mesenchymal transition, stage 3) icon PNG

Enterocyte (epithelial���mesenchymal transition, stage 3) icon SVG

Enterocyte (epithelial���mesenchymal transition, stage 3) icon GIF

BioRender 图标常见问题解答

How are scientists using the Enterocyte (epithelial���mesenchymal transition, stage 3) icon in their work?

BioRender users often use the Enterocyte (epithelial���mesenchymal transition, stage 3) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

我可以在 BioRender 图表或科学插图中使用此图标吗?

Yes, the Enterocyte (epithelial���mesenchymal transition, stage 3) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Enterocyte (epithelial���mesenchymal transition, stage 3) icon customizable in BioRender?

Most icons in BioRender, including the Enterocyte (epithelial���mesenchymal transition, stage 3) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Enterocyte (epithelial���mesenchymal transition, stage 3) icon for publication or presentations?

Yes, figures containing the Enterocyte (epithelial���mesenchymal transition, stage 3) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Enterocyte (epithelial���mesenchymal transition, stage 3) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Enterocyte (epithelial���mesenchymal transition, stage 3) icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

什么是 BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Enterocyte (epithelial���mesenchymal transition, stage 3) icon along with our library of more than 30,000 life science icons.

在 BioRender 中使用此图标

立即开始制作专业的科学图表
antibody elements3D Phospholipid illustration

正在寻找科学内容?

浏览超过 5 万个经同行评审、易于使用且免费的图标和模板。

立即寻找您的专属素材
x icon